参考资料:[1] Zwirner S, Abu Rmilah AA, Klotz S, Pfaffenroth B, Kloevekorn P,et al. First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure. Cell. 2024 Mar 8:S0092-8674(24)00225-3. doi: 10.1016/j.cell.2024.02.023. Epub ahead of print. PMID: 38490194.[2] Next milestone in the treatment of liver tumors and acute and chronic liver diseases,Retrieved March 19, 2024, from https://www.medizin.uni-tuebingen.de/en-de/das-klinikum/pressemeldungen/628[3] Researchers find promise in new potential treatment for liver failure,Retrieved March 19, 2024, from https://newsnetwork.mayoclinic.org/discussion/researchers-find-promise-in-new-potential-treatment-for-liver-failure/
免责声明:药明康德内容团队专注介绍全球生物医药健康研究进展。本文仅作信息交流之目的,文中观点不代表药明康德立场,亦不代表药明康德支持或反对文中观点。本文也不是治疗方案推荐。如需获得治疗方案指导,请前往正规医院就诊。
版权说明:本文来自药明康德内容团队,欢迎个人转发至朋友圈,谢绝媒体或机构未经授权以任何形式转载至其他平台。转载授权请在「药明康德」微信公众号回复“转载”,获取转载须知。